Abstract
Successful experimental epikeratophakia grafting was done with the use of a biological adhesive. The use of an adhesive eliminated the need for any suturing of the corneal lenticule to the host cornea, and this method reduced the length of the operative procedure to only one third of the time that is taken when sutures are used. Tisseel (Immuno AG, Vienna), a commercially available two-component adhesive system based on human fibrinogen, which is activated by thrombin, was used. The glue was used in combination with an antifibrinolytic agent. With alteration of the operative technique and lenticule design, 70% of glued epikeratophakia grafts in a rabbit model were retained, compared with a 50% success rate with grafts applied without the use of an adhesive.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
